|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date20 Dec 2021 |
|
MechanismProtective antigen inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date18 Mar 2016 |
100 Clinical Results associated with SFL Pharmaceuticals Deutschland GmbH
0 Patents (Medical) associated with SFL Pharmaceuticals Deutschland GmbH
100 Deals associated with SFL Pharmaceuticals Deutschland GmbH
100 Translational Medicine associated with SFL Pharmaceuticals Deutschland GmbH